Furthermore, the overexpression of MYBL2 was associated with poor prognosis across various tumor types including ACC, KIRC, BRCA, LGG, KIRP, PAAD, LIHC, THCA, PRAD, and UCEC (Fig. 5B). This evidence concerns the gene MYBL2 and neoplasm.